For example, in papillary thyroid cancer, IGF2BP2 increases the translational efficiency of erb-b2 receptor tyrosine kinase 2 (ERBB2) by binding to m6A motifs in its coding sequence (CDS), thereby conferring resistance to tyrosine kinase inhibitors [66]. This evidence concerns the gene ERBB2 and thyroid gland papillary carcinoma.